Dr. Carlezon and his group were the first to report that a class of drugs called
kappa - opioid receptor (KOR) antagonists has antidepressant, anti-anxiety, and anti-stress effects in their behavioral
tests.
Kappas for individual codes were also tested to control for chance agreement (kappas ranged from.58 to 1.0, mean kappa
Kappas for individual codes were also
tested to control for chance agreement (
kappas ranged from.58 to 1.0, mean kappa
kappas ranged from.58 to 1.0, mean
kappa =.83).